Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Triolo

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
Reviews on Recent Clinical Trials|March 16, 2018
The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and DiabetesPiero Ruscitti, Paola Cipriani, Vasiliky Liakouli, et al.
The Journal of Rheumatology|April 17, 2018
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale CohortPiero Ruscitti, Daniela Iacono, Francesco Ciccia, et al.
Rheumatology (Oxford, England)|April 12, 2015
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritisFrancesco Ciccia, Aroldo Rizzo, Giuliana Guggino, et al.
Rheumatology International|January 8, 2017
Interstitial lung disease in systemic sclerosis: current and future treatmentRoberto Giacomelli, Vasiliki Liakouli, Onorina Berardicurti, et al.
Arthritis and Rheumatism|April 1, 2009
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitisFrancesco Ciccia, Michele Bombardieri, Alfonso Principato, et al.
Clinical and Experimental Rheumatology|July 7, 2017
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trialMassimiliano Curatolo, Giuseppe La Bianca, Giuseppe Cosentino, et al.
Rheumatology (Oxford, England)|October 2, 2013
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitisFrancesco Ciccia, Riccardo Alessandro, Aroldo Rizzo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 25, 2014
Brief Report: Intestinal Dysbiosis in Ankylosing SpondylitisMary-Ellen Costello, Francesco Ciccia, Dana Willner, et al.
Rheumatology (Oxford, England)|March 7, 2014
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activityFrancesco Ciccia, Aroldo Rizzo, Riccardo Alessandro, et al.
Annals of the Rheumatic Diseases|August 9, 2012
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritisFrancesco Ciccia, Riccardo Alessandro, Aroldo Rizzo, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
Reviews on Recent Clinical Trials|March 16, 2018
The Emerging Role of IL-1 Inhibition in Patients Affected by Rheumatoid Arthritis and DiabetesPiero Ruscitti, Paola Cipriani, Vasiliky Liakouli, et al.
The Journal of Rheumatology|April 17, 2018
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale CohortPiero Ruscitti, Daniela Iacono, Francesco Ciccia, et al.
Rheumatology (Oxford, England)|April 12, 2015
Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritisFrancesco Ciccia, Aroldo Rizzo, Giuliana Guggino, et al.
Rheumatology International|January 8, 2017
Interstitial lung disease in systemic sclerosis: current and future treatmentRoberto Giacomelli, Vasiliki Liakouli, Onorina Berardicurti, et al.
Arthritis and Rheumatism|April 1, 2009
Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitisFrancesco Ciccia, Michele Bombardieri, Alfonso Principato, et al.
Clinical and Experimental Rheumatology|July 7, 2017
Motor cortex tRNS improves pain, affective and cognitive impairment in patients with fibromyalgia: preliminary results of a randomised sham-controlled trialMassimiliano Curatolo, Giuseppe La Bianca, Giuseppe Cosentino, et al.
Rheumatology (Oxford, England)|October 2, 2013
Macrophage phenotype in the subclinical gut inflammation of patients with ankylosing spondylitisFrancesco Ciccia, Riccardo Alessandro, Aroldo Rizzo, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 25, 2014
Brief Report: Intestinal Dysbiosis in Ankylosing SpondylitisMary-Ellen Costello, Francesco Ciccia, Dana Willner, et al.
Rheumatology (Oxford, England)|March 7, 2014
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activityFrancesco Ciccia, Aroldo Rizzo, Riccardo Alessandro, et al.
Annals of the Rheumatic Diseases|August 9, 2012
IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritisFrancesco Ciccia, Riccardo Alessandro, Aroldo Rizzo, et al.
Pageof 9